Sickness beneficiary Warren Edney, who suffers immensely from a rapidly progressing form of MS, on his need for Medical Cannabis, to support Warren, and others like him, please consider donating to him on our give a little page. Read More
Authors Slof J, Ruiz L, Vila C.Abstract;Multiple sclerosis (MS) is a chronic progressive disease that carries a high socioeconomic burden. Spasticity (rigidity and spasms) is common in MS and contributes to MS-related disability. This study aims to evaluate the cost-effectiveness of Sativex(®) (9-delta-tetrahydrocannabinol plus cannabidiol oromucosal spray) when used as add-on therapy fo... Read More
Author: Trojano M.
AbstractOnce the efficacy and tolerability of a new intervention have been demonstrated in clinical trials under ideal experimental conditions, observational studies within approved label conditions are performed to determine its effectiveness in real-world use and expand the safety/tolerability data. Several large observational studies have been conducted of Sativex(®) (THC:... Read More
Authors Coghe G, Pau M, Corona F, Frau J, Lorefice L, Fenu G, Spinicci G, Mamusa E, Musu L, Massole S Massa R, Marrosu MG, Cocco E.Abstract: Recently, nabiximols was approved as a treatment in MS spasticity. Data leading to approval and clinical use of nabiximols, although widely recognised, are based on subjective scales. Movement analysis procedures would obtain more detailed data about the... Read More
Original source is Journal of the American Medical Society June 23/30, 2015, Vol 313, No. 24
Importance Cannabis and cannabinoid drugs are widely used to treat disease or alleviate symptoms, but their efficacy for specific indications is not clear.Objective To conduct a systematic review of the benefits and adverse events (AEs) of cannabinoids.Data Sources Twenty-ei... Read More